Patrick Haslett
4Patents
0h-index
15Co-inventors
31Inventor score
Filing activity: May 23, 2014 → Jul 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11034957B2 | Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11059906B2 | Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma | Chemistry; Metallurgy | 0 | Active |
| US10578624B2 | Determination of glycosaminoglycan levels by mass spectrometry | Physics | 0 | Active |
| US10639356B2 | Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathecal delivery of heparan N-sulfatase | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.